Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T07400 | Target Info | |||
Target Name | Advanced glycosylation end product receptor (AGER) | ||||
Synonyms | Receptor foradvanced glycosylation end products; RAGESEC; RAGE; AGER | ||||
Target Type | Clinical trial Target | ||||
Gene Name | AGER | ||||
Biochemical Class | Immunoglobulin | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 3-Phenoxyphenol | Ligand Info | |||
Canonical SMILES | C1=CC=C(C=C1)OC2=CC=CC(=C2)O | ||||
InChI | 1S/C12H10O2/c13-10-5-4-8-12(9-10)14-11-6-2-1-3-7-11/h1-9,13H | ||||
InChIKey | HBUCPZGYBSEEHF-UHFFFAOYSA-N | ||||
PubChem Compound ID | 12842 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6XQ8 Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 11 | ||||||
Method | X-ray diffraction | Resolution | 1.82 Å | Mutation | No | [1] |
PDB Sequence |
GAMAQNITAR
29 IGEPLVLKCK39 GAPKKPPQRL49 EWKLNTGRTE59 AWKVLSPQGG69 GPWDSVARVL 79 PNGSLFLPAV89 GIQDEGIFRC99 QAMNRNGKET109 KSNYRVRVYQ119 IPGKPEIVDS 129 ASELTAGVPN139 KVGTCVSEGS149 YPAGTLSWHL159 DGKPLVPNEK169 GVSVKEQTRR 179 HPETGLFTLQ189 SELMVTPARG199 GDPRPTFSCS209 FSPLRTAPIQ226 PRVWE |
|||||
|
||||||
PDB ID: 6XQ6 Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 11 | ||||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | No | [1] |
PDB Sequence |
GAMAQNITAR
29 IGEPLVLKCK39 GAPKKPPQRL49 EWKLNTGRTE59 AWKVLSPQGG69 GPWDSVARVL 79 PNGSLFLPAV89 GIQDEGIFRC99 QAMNRNGKET109 KSNYRVRVYQ119 IPGKPEIVDS 129 ASELTAGVPN139 KVGTCVSEGS149 YPAGTLSWHL159 DGKPLVPNEK169 GVSVKEQTRR 179 HPETGLFTLQ189 SELMVTPARG199 GDPRPTFSCS209 FSPGLAPIQP227 RVWE |
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors. Proteins. 2021 Nov;89(11):1399-1412. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.